Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To prevent across-the-board direct spending cuts, and for other purposes.
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, and telehealth. Issues related to reimbursement for COVID testing and vaccination. P.L. 117-2, The American Rescue Plan Act of 2021 S. 150, The Ensuring Parity for MA in Audio-only Telehealth Act of 2021 S. 368, The Telehealth Modernization Act S. 748, The Medicare Sequester Relief Act of 2021 H.R. 366, The Protecting Access to Post-COVID Telehealth Access Act of 2021 H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes H.R. 2166 The Ensuring Parity for MA and PACE in Audio-only Telehealth Act of 2021
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2021 · first_quarter · Q1
Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, and telehealth. Issues related to reimbursement for COVID testing and vaccination. P.L. 117-2, The American Rescue Plan Act of 2021 S. 150, The Ensuring Parity for MA in Audio-only Telehealth Act of 2021 S. 368, The Telehealth Modernization Act S. 748, The Medicare Sequester Relief Act of 2021 H.R. 366, The Protecting Access to Post-COVID Telehealth Access Act of 2021 H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes H.R. 2166 The Ensuring Parity for MA and PACE in Audio-only Telehealth Act of 2021
Source: Senate LDA
Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, and telehealth. Issues related to reimbursement for COVID testing and vaccination. P.L. 117-2, The American Rescue Plan Act of 2021 S. 150, The Ensuring Parity for MA in Audio-only Telehealth Act of 2021 S. 368, The Telehealth Modernization Act S. 748, The Medicare Sequester Relief Act of 2021 H.R. 366, The Protecting Access to Post-COVID Telehealth Access Act of 2021 H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes H.R. 2166 The Ensuring Parity for MA and PACE in Audio-only Telehealth Act of 2021
Protecting Access to Post-COVID–19 Telehealth Act of 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, and telehealth. Issues related to reimbursement for COVID testing and vaccination. P.L. 117-2, The American Rescue Plan Act of 2021 S. 150, The Ensuring Parity for MA in Audio-only Telehealth Act of 2021 S. 368, The Telehealth Modernization Act S. 748, The Medicare Sequester Relief Act of 2021 H.R. 366, The Protecting Access to Post-COVID Telehealth Access Act of 2021 H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes H.R. 2166 The Ensuring Parity for MA and PACE in Audio-only Telehealth Act of 2021
Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, and telehealth. Issues related to reimbursement for COVID testing and vaccination. P.L. 117-2, The American Rescue Plan Act of 2021 S. 150, The Ensuring Parity for MA in Audio-only Telehealth Act of 2021 S. 368, The Telehealth Modernization Act S. 748, The Medicare Sequester Relief Act of 2021 H.R. 366, The Protecting Access to Post-COVID Telehealth Access Act of 2021 H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes H.R. 2166 The Ensuring Parity for MA and PACE in Audio-only Telehealth Act of 2021
Telehealth Modernization Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, and telehealth. Issues related to reimbursement for COVID testing and vaccination. P.L. 117-2, The American Rescue Plan Act of 2021 S. 150, The Ensuring Parity for MA in Audio-only Telehealth Act of 2021 S. 368, The Telehealth Modernization Act S. 748, The Medicare Sequester Relief Act of 2021 H.R. 366, The Protecting Access to Post-COVID Telehealth Access Act of 2021 H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes H.R. 2166 The Ensuring Parity for MA and PACE in Audio-only Telehealth Act of 2021
Medicare Sequester Relief Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to Medicare Part D, Medicare Advantage, Medicaid, the ESRD program, and telehealth. Issues related to reimbursement for COVID testing and vaccination. P.L. 117-2, The American Rescue Plan Act of 2021 S. 150, The Ensuring Parity for MA in Audio-only Telehealth Act of 2021 S. 368, The Telehealth Modernization Act S. 748, The Medicare Sequester Relief Act of 2021 H.R. 366, The Protecting Access to Post-COVID Telehealth Access Act of 2021 H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes H.R. 2166 The Ensuring Parity for MA and PACE in Audio-only Telehealth Act of 2021
Consolidated Appropriations Act, 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Consolidated Appropriations Act, 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 4124, Healthy Workplaces Tax Credit H.R. 133, Consolidated Appropriations Act, 2021
Consolidated Appropriations Act, 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing and vaccination. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 133, Consolidated Appropriations Act, 2021
Consolidated Appropriations Act, 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act H.R. 133, Consolidated Appropriations Act, 2021
Prescription Drug STAR Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
JOBS Credit Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020 H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
JOBS Credit Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
JOBS Credit Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 4124, Healthy Workplaces Tax Credit H.R. 133, Consolidated Appropriations Act, 2021
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing and vaccination. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 133, Consolidated Appropriations Act, 2021
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 4124, Healthy Workplaces Tax Credit H.R. 133, Consolidated Appropriations Act, 2021
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020 H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
INFORM Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to organized retail crime and product safety. H.R. 7756/S. 3417, The Integrity, Notification and Fairness in Online Retail Marketplaces for Consumers Act of 2020
INFORM Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to organized retail crime and product safety. H.R. 7756/S. 3417, The Integrity, Notification and Fairness in Online Retail Marketplaces for Consumers Act of 2020
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
The Dr. Joseph Costa Honoring Essential Americans Risking Their Safety Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
The Dr. Joseph Costa Honoring Essential Americans Risking Their Safety Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
FAST Generics Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosimilar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing and vaccination. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 133, Consolidated Appropriations Act, 2021
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act H.R. 133, Consolidated Appropriations Act, 2021
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Chronic Disease Management Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020
Chronic Disease Management Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020 H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act H.R. 133, Consolidated Appropriations Act, 2021
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing and vaccination. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 133, Consolidated Appropriations Act, 2021
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Patient Access to ESRD New Innovative Devices Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Patient Access to ESRD New Innovative Devices Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to medication adherence, drug pricing transparency, prescription drug abuse, and COVID testing and vaccination, including the Federal Retail Pharmacy Program. P.L. 117-2, The American Rescue Plan Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2020 · fourth_quarter · Q4
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing and vaccination. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 133, Consolidated Appropriations Act, 2021
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. Issues related to reimbursement levels for COVID testing and vaccination. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act H.R. 133, Consolidated Appropriations Act, 2021
Issues related to organized retail crime and product safety. H.R. 7756/S. 3417, The Integrity, Notification and Fairness in Online Retail Marketplaces for Consumers Act of 2020
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 4124, Healthy Workplaces Tax Credit H.R. 133, Consolidated Appropriations Act, 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2020 · third_quarter · Q3
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act
Issues related to implementation and changes to the Affordable Care Act.
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to organized retail crime and product safety. H.R. 7756/S. 3417, The Integrity, Notification and Fairness in Online Retail Marketplaces for Consumers Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2020 · second_quarter · Q2
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020 H.R. 6776, The JOBS Credit Act of 2020 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2020 · first_quarter · Q1
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to barriers to generic drug and biosimilar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · fourth_quarter · Q4
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · third_quarter · Q3
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · second_quarter · Q2
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · first_quarter · Q1
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · fourth_quarter · Q4
Issues related to prescription drug abuse, medication adherence, and drug price transparency. H.R. 1316, The Prescription Drug Price Transparency Act of 2017 H.R. 5343, The Prescription Transparency Act of 2018 H.R. 6, The SUPPORT for Patients and Communities Act of 2018
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · third_quarter · Q3
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Issues related to CVS Health announced merger with Aetna.
Issues related to prescription drug abuse, medication adherence, drug price transparency, and gag clauses. H.R. 1316, The Prescription Drug Price Transparency Act of 2017 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 S. 2554/H.R. 6143, The Patient Right to Know Drug Prices Act of 2018 H.R. 5343, The Prescription Transparency Act of 2018 H.R. 6, The SUPPORT for Patients and Communities Act of 2018 S. 2680, The Opioids Crisis Response Act
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · second_quarter · Q2
Issues related to prescription drug abuse and Medicare Part D. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Securely Act of 2017 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 H.R. 4841, The Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R. 5958, The Phair Pricing Act of 2018
Issues related to prescription drug abuse, medication adherence, drug price transparency, and gag clauses. H.R. 1316, The Prescription Drug Price Transparency Act of 2017 S. 778/H.R. 1854, The Prescription Drug Monitoring Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Securely Act of 2017 S. 892/H.R. 4408, The Opioid Addiction Prevention Act of 2017 S. 2456/H.R. 5311, The CARA 2.0 Act of 2018 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 S. 2554/H.R. 6143, The Patient Right to Know Drug Prices Act of 2018 H.R. 5343, The Prescription Transparency Act of 2018 H.R. 6, The SUPPORT for Patients and Communities Act of 2018 H.R. 6133, The Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · first_quarter · Q1
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Issues related to prescription drug abuse, medication adherence, generic drug approvals, biologic exclusivity periods, drug price transparency, and gag clauses. H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 778/H.R. 1854, The Prescription Drug Monitoring Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S.892/H.R. 4408, The Opioid Addiction Prevention Act of 2017 S. 2456 / H.R. 5311, The CARA 2.0 Act of 2018 H.R. 4482, The Opioid Abuse Deterrence, Research, and Recovery Act of 2017 S. 2553, The Know the Lowest Price Act of 2018 S. 2554, The Patient Right to Know Drug Prices Act of 2018 H.R. 5343, The Prescription Transparency Act of 2018
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2017 · fourth_quarter · Q4
Issues related to CVS Health announced merger with Aetna.
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.1316, The Prescription Drug Price Transparency Act of 2017 S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act of 2017 S. 778/H.R. 1854, The Prescription Drug Monitoring Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S.892, The Opioid Addiction Prevention Act of 2017
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2017 · third_quarter · Q3
Issues related to corporate tax reform and taxes included in the Affordable Care Act.
Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.1316, The Prescription Drug Price Transparency Act of 2017 S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act of 2017 H.R.749, The Lower Drug Costs Through Competition Act of 2017 S. 297, The Increasing Competition in Pharmaceuticals Act of 2017 S. 778/H.R. 1854, The Prescription Drug Monitoring Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2017 · second_quarter · Q2
Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act H.R. 2051, The Fair Access for Safe and Timely Generics Act S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2017 · first_quarter · Q1
Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214 Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2016 · fourth_quarter · Q4
Issues related to proposed rule modifying retailer eligibility requirements in Supplemental Nutrition Assistance Program (SNAP)
H.R.2712-Commonsense Reporting and Verification Act of 2015 S.1996-Commonsense Reporting Act of 2015 H.R.34 - 21st Century Cures Act (H.R.6) S.533-Tsunami Warning, Education, and Research Act of 2015 (21st Century Cures Act)
Issues related to implementation of Section 1557 of ACA HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2016 · third_quarter · Q3
Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. Issues related to FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S. 524, HR 953-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)
HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 4062 - Protecting Seniors Access to Proper Care Act of 2015 HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act H.R. 5951-Improving Transparency and Accuracy in Medicare Part D Spending Act
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2016 · second_quarter · Q2
Medicare/Medicaid-Issues related to plan design, reimbursement, audit and cost savings proposals. Issues related to Part D prescriber enrollment. HR 793 - Ensuring Seniors Access to Local Pharmacies Act
Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2016 · first_quarter · Q1
Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
Issues related to employer, small group and individual insurance markets, including surprise billing. S. 657, The Drug Price Transparency Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Issues related to prescription drug abuse and Medicare Part D. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 H.R. 5958, The Phair Pricing Act of 2018 H.R. 4143/S. 2065, The Dialysis PATIENTS Demonstration Act of 2017
Issues related to CVS Health announced merger with Aetna.
Issues related to implementation and changes to the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to implementation and changes to the Affordable Care Act.
Issues related to prescription drug abuse and Medicare Part D. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 H.R. 5958, The Phair Pricing Act of 2018 H.R. 4143/S. 2065, The Dialysis PATIENTS Demonstration Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to implementation and changes to the Affordable Care Act.
Issues related to CVS Health announced merger with Aetna.
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to implementation and changes to the Affordable Care Act.
Issues related to health savings accounts, the health insurance tax and other taxes included in the Affordable Care Act. S. 1859, the Healthcare Tax Relief Act of 2017 H.R. 95, Making Further Continuing Appropriations for the fiscal year ending September 30, 2018 H.R. 4620, the Protecting Families and Small Business Act of 2018 H.R. 5138, the Bipartisan HSA Improvement Act of 2018
Issues related to CVS Health announced merger with Aetna.
Issues related to prescription drug abuse, Medicare Part D, and Medicare payment for home infusion. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017 S. 2553, The Know the Lowest Price Act of 2018 H.R. 4841, The Standardizing Electronic Prior Authorization for Safe Prescribing Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to Medicare Part D and Medicare payment for home infusion. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017
Issues related to corporate tax reform, health savings accounts, and taxes included in the Affordable Care Act. H.R.1, The Tax Cuts and Jobs Act H.R. 4620, The Protecting Families and Small Businesses Act of 2017
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act of 2017 S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017 H.R. 3823, The Disaster Tax Relief and Airport and Airway Extension Act of 2017
Issues related to implementation and changes to the Affordable Care Act.
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act
Issues related to corporate tax reform. S.638/H.R.1296, The Promoting More American Manufacturing Jobs Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to implementation and changes to the Affordable Care Act.
Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA)
Medicare/Medicaid-Issues related to plan design, reimbursement, audit and cost savings proposals. Issues related to Part D Prescriber enrollment. HR 793 - Ensuring Seniors Access to Local Pharmacies Act
Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE